Top Markets
Coin of the day
GlycoNex Incorporation GlycoNex Incorporation

GlycoNex Incorporation

4168
Helyezés a részvények között #22943
GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in... GlycoNex Incorporation, based in New Taipei City, Taiwan, specializes in developing innovative cancer therapeutics. The company achieves this by leveraging advanced glycosphingolipid antigen and human monoclonal antibody technologies. Its robust pipeline for solid tumors features several investigational antibody drugs. These include GNX102, a humanized monoclonal antibody currently in Phase 1 clinical trials; GNX201, an antibody candidate undergoing lead optimization; and GNX202, which is in preclinical development. Additionally, GNX203 and GNX204 are antibody drugs presently in the target validation stage. Beyond oncology, GlycoNex is also advancing other therapeutic agents. This includes SPD (Denosumab), a humanized IgG2 antibody in preclinical stages for both osteoporosis and oncology indications. Another key asset is SEA (Aflibercept), a vascular endothelial growth factor (VEGF) binding fusion protein, currently undergoing lead optimization for its potential use in ophthalmology and oncology. GlycoNex was established in 2001.
Részvényárfolyam
$0.71865803
Utolsó szinkronizálás: 2026-08-21
Piaci kapitalizáció
$80.86M
Változás (1 nap)
0.00%
Változás (1 év)
-5.48%
Ország
TW
Kereskedés GlycoNex Incorporation (4168)

Kategória

GlycoNex Incorporation (4168) részvényárfolyamának története
Legmagasabb napi záróár: $0.72 ekkor: 2026-08-01

Legalacsonyabb napi záróár: $2.55 ekkor: 2012-06-01
GlycoNex Incorporation részvényárfolyamának története 2012 és 2026 között
Éves részvényárfolyam teljesítmény
Év Teljesítmény
2026 (TTM) 4.61%
2025 -1.85%
2024 -14.27%
2023 -16.58%
2022 0.65%
2021 19.55%
2020 36.23%
2019 -14.54%
2018 0.91%
2017 -26.75%
2016 -41.27%
2015 -21.61%
2014 -32.30%
2013 -27.14%
2012 0.00%
Hasonló cégek vagy versenytársak részvényárai
Vállalat Részvényár Változás 1év% Ország
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH